Title |
A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
|
---|---|
Published in |
PLOS ONE, August 2012
|
DOI | 10.1371/journal.pone.0042284 |
Pubmed ID | |
Authors |
Miriam K. Laufer, Phillip C. Thesing, Fraction K. Dzinjalamala, Osward M. Nyirenda, Rhoda Masonga, Matthew B. Laurens, Abbie Stokes-Riner, Terrie E. Taylor, Christopher V. Plowe |
Abstract |
The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner drugs to preserve chloroquine efficacy and prevent the re-emergence of resistance. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 3% |
Unknown | 88 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 19% |
Student > Master | 14 | 15% |
Student > Ph. D. Student | 9 | 10% |
Student > Postgraduate | 7 | 8% |
Student > Doctoral Student | 6 | 7% |
Other | 20 | 22% |
Unknown | 18 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 23% |
Biochemistry, Genetics and Molecular Biology | 11 | 12% |
Agricultural and Biological Sciences | 10 | 11% |
Nursing and Health Professions | 6 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 16 | 18% |
Unknown | 23 | 25% |